Deinove protects its bacteria derived feed innovation in China

© istock/ipopba

French biotech company, Deinove, says its first patent focusing on the use of the bacteria, Deinococcus, for animal nutrition has been issued in China.

Emmanuel Petiot, CEO of the Montpellier based company, said the patent demonstrates the progress it has made in the animal nutrition sector in the past three years.

“China is the world's largest producer of livestock, it is therefore essential that we can eventually market our innovations there with all the necessary protections. However, this patent is intended to be issued in all other major territories,” he added.

Deinove has nearly 160 international patent applications. 

The company, which has been working to develop applications for its biotechnologies in the animal nutrition market, in particular through two partnership programs, has been listed on Alternext since April 2010. To do this it says it relies on two key assets: 

  • A strain bank with 6,000 rare bacteria that have not yet been exploited, mainly of the Deinococcus genus;
  • A genetic, metabolic and fermentation engineering platform that enables it to customize these natural micro-factories 

Pigmentation, antioxidant functionality

Last month, we heard from the CEO as the firm announced that the effectiveness and bioavailability of its carotenoid compounds, derived from seven strains, had been confirmed in in vivo animal trials.

Those studies were run under the Color2B strategic project, in which Deinove collaborates with French agribusiness group, Avril.

“The compounds are used mainly for pigmentation of skin and yolks but they do have nutritional value as well - antioxidant functionality,” Petiot told this publication then.

Avril is hoping to leverage the huge demand for natural coloring options. Europe will be likely the first market it enters with the biobased carotenoids, then Asia and the US will follow, he said.

Broilers and layers in the poultry industry, and the salmon and trout farming sectors in the aquaculture arena are the likely target markets for the carotenoids, said

However, regulatory approvals have to be secured and licensing models developed – it is anticipated commercialization of the compounds would begin around 2019.

The next phase of the Color2B project involves optimizing high performing strains and production conditions along with further validation work. “We now need to carry out extensive in vivo trials to replicate findings with a wider amount of animals, and we need to produce more bacteria biomass,” he said.

Related News

© iStock

Start-up targets EU with poultry feed additive product, lacking US market understanding

© istock/Aquir

DuPont subsidiary files patent for stable enzyme feed granules

© istock/pepsikan

French company's bio-based carotenoids pass test with flying colors


French biotech firm has feed ambitions for carotenoid platform

Copyright Deinove. Project aims to select bacteria strains that produce compounds such as natural carotenoids and enzymes

French agribusiness and biotech tie-up looks to develop bacteria derived feed additives


What do German efficiency and lysine producing bacteria have in common?

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.